
Canada is facing criticism for funding a COVID-19 vaccine candidate developed by the Chinese company CanSino. Although it was approved for human trials in Canada, it still hasn’t arrived more than three-months after it was given the green light. As Redmond Shannon explains, there are concerns that rocky relations between the two countries may be to blame.













